Sat.Jan 23, 2021 - Fri.Jan 29, 2021

Gene therapy for hemophilia: So close, yet so far away

Bio Pharma Dive

Significant setbacks for pace-setting programs from BioMarin and UniQure have renewed questions about gene therapy’s promise, and its safety

10 Essential pharma content strategy must-haves

World of DTC Marketing

SUMMARY: Pharma has not embraced a content strategy when the number of online health seekers is climbing. A content management strategy can lead to a better brand-patient relationship and turn customers into brand ambassadors. I’m not a huge believer in content strategy for CPGs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

In ED patients with chest and abdominal pain, care delivered by physicians and APPs is similar

Scienmag

Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM.

Over-the-Counter Nasal Spray Could Be Effective Against COVID-19

BioSpace

An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient

Vaccine makers prepare response as coronavirus mutations raise alarms

Bio Pharma Dive

So far, both Pfizer's and Moderna's vaccines appear to work against more transmissible variants, but preparation is underway for the day they don't

The complicated ROI measurement for pharma

World of DTC Marketing

SUMMARY: The LinkedIn team had a unique take on measuring ROI. “77% of marketers measure ROI within the first month of their campaign, knowingly trying to “prove ROI in a shorter amount of time than their typical sales cycle.,

Scientists publish a blueprint to apply artificial intelligence to extend human longevity

Scienmag

More Trending

Sanofi, in unusual move, to help Pfizer, BioNTech make coronavirus vaccine doses

Bio Pharma Dive

The French drugmaker, having hit delays with its own coronavirus shot, agreed to manufacture over 100 million doses of Pfizer and BioNTech's vaccine for supply in Europe

Healthcare is heading for a day of reckoning

World of DTC Marketing

SUMMARY: The current state of healthcare is unsustainable. Please read that again. There are too many players who are taking too much money in profits while adding little if any value.

Are Gene Therapies the Medicine of the Future?

BioSpace

Gene therapies offer great reward in the form of treating various devastating diseases, but there are also significant risks

Colorado RFP on Drug Importation Accounts for Canada’s Order Protecting Against Shortages

Pharmacy Checkers

This week, the Colorado Department of Health Care Policy and Financing issued a request for proposals, called an Invitation to Negotiate, to operate a state wholesale drug importation program as permitted under federal law and the administrative final rule issued by HHS last year, referred to as the Section 804 rule.

J&J says single dose of coronavirus vaccine 66% effective in large trial

Bio Pharma Dive

The vaccine's efficacy was higher in the U.S., but lower in Latin America and South Africa, where new, more infectious virus variants are circulating

Trials 273

Is pharma digital ready?

World of DTC Marketing

SUMMARY: Digital is a way of thinking; it’s not a tactic. To many going digital can mean a ton of opportunities but if you move too quickly you can lose sight of the end goal. Is your organization digital ready?

UPDATE: Bomb Threat Forces Evacuation of AstraZeneca COVID-19 Vaccine Manufacturing Plant

BioSpace

Police have sealed off the area, according to the report. Few details were available, but eye witnesses said a robot was investigating a suspicious package found at the plant

What we’re expecting in 2021, and beyond…

Pharma Phorum

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year.

Merck stops coronavirus vaccine development in surprise setback

Bio Pharma Dive

The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials

Selling digital to skeptics within pharma

World of DTC Marketing

SUMMARY: The future of healthcare involves digital transformation but moving too fast in a matrix management environment can cause problems and set digital back months. Most of us know the importance of digital when to comes to healthcare.

European Commission Raids AstraZeneca’s Belgian Vaccine Plant

BioSpace

Regulators removed samples and records from the plant, which are being examined by experts from Belgium, the Netherlands, Italy, and Spain

COVID-19 pandemic led to decreased school meal access for children in need across Maryland

Scienmag

Safety finding weighs on Pfizer's inflammation drug, and could spell trouble for others

Bio Pharma Dive

A large safety study found that patients given Pfizer's Xeljanz had health issues like major heart complications and cancer at a higher rate than those who got a different kind of anti-inflammation drug

Drugs 263

Biden Pledges to Speed Flow of Vaccines to the States

NY Times

President Biden said the amount of coronavirus vaccines reaching the states would rise next week and a deal was near to provide enough shots to vaccinate nearly all Americans by the end of summer.

Healthcare.gov Special Enrollment Period 2/15/21 to 5/15/21

Triage Cancer

Yesterday, President Biden signed an Executive Order, directing the Department of Health and Human Services to open Healthcare.gov for a Special Enrollment Period (SEP).

69

By changing their shape, some bacteria can grow more resilient to antibiotics

Scienmag

Credit: Shiladitya Banerjee New research led by Carnegie Mellon University Assistant Professor of Physics Shiladitya Banerjee demonstrates how certain types of bacteria can adapt to long-term exposure to antibiotics by changing their shape.

FDA approves first-of-its-kind lupus drug

Bio Pharma Dive

Lupkynis, the first oral drug approved for lupus nephritis, comes with a high list price. Its developer, Aurinia Pharmaceuticals, expects average net revenue of roughly $65,000 per patient per year

In Israel, Infections Drop Sharply After One Shot of Vaccine

NY Times

Initial studies show a significant drop in infections and hospitalizations after just one dose, and very few cases after two. Experts caution that the results are preliminary.

Vertex Moves Full Steam Ahead on Type 1 Diabetes Drug Trial With FDA’s OK

BioSpace

The U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug application that will allow Boston-based Vertex Pharmaceuticals to proceed with a clinical trial of its investigational stem cell-derived, fully differentiated pancreatic islet cell treatment for type 1 diabetes

Our gut-brain connection

Scienmag

‘Organs-on-a-chip’ system sheds light on how bacteria in the human digestive tract may influence neurological diseases Credit: Martin Trapecar, MIT CAMBRIDGE, MA — In many ways, our brain and our digestive tract are deeply connected.

Can new Regeneron, Lilly data move the needle for COVID-19 antibody drugs?

Bio Pharma Dive

The results show that drugs from both companies can help prevent or treat COVID-19 when given at the right time. But that won't mean much if barriers to use remain high

Early studies suggest Pfizer/BioNTech vaccine is effective against South African strain

BioPharma Reporter

In vitro studies found the Pfizer/BioNTech COVID-19 vaccine elicits antibodies against both the UK and South African virus strains. Bio Developments

Pharma Industry Comes Together to Support Manufacture of COVID-19 Vaccines

BioSpace

The pharmaceutical industry continues to demonstrate its willingness to team up in the ongoing combat against the global COVID-19 pandemic

Researchers identify existing drug’s potential for triple negative breast cancer

Pharma Times

Study suggests that palbociclib could be used to treat around a fifth of people with TNBC

With latest deal, Merck wades into cell therapy for cancer

Bio Pharma Dive

A small upfront payment gives Merck access to a program from Artiva Biotherapeutics that aims to create "off-the-shelf" CAR-NK cell therapies for solid tumors

228
228

AstraZeneca and University of Oxford dismiss German media claims about vaccine efficacy in elderly

BioPharma Reporter

AstraZeneca along with its scientific partners at the University of Oxford have rejected German media reports that their vaccine against COVID-19 had low efficacy in people aged over 65. Markets & Regulations

Gene editing: beyond the hype

Pharma Phorum

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space.

Moderna says its COVID-19 vaccine works effectively against variants

Pharma Times

Lab tests evaluated vaccine's efficacy against UK and South African variants

Novartis joins Sanofi in aiding manufacture of coronavirus vaccines

Bio Pharma Dive

A deal to fill vials of Pfizer and BioNTech's vaccine could be the first of several Novartis signs to help others make COVID-19 treatments

Medicaid expansion helps uncover undiagnosed HIV infections

Scienmag

Credit: Photo by L. Brian Stauffer CHAMPAIGN, Ill.

Drugs 65